Pharmacological inhibition of BAP1 recruits HERC2 to competitively dissociate BRCA1–BARD1, suppresses DNA repair and sensitizes CRC to radiotherapy
Open Access
- 19 May 2023
- journal article
- research article
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 13 (8) , 3382-3399
Abstract
No abstract availableKeywords
Funding Information
- Basic and Applied Basic Research Foundation of Guangdong Province (2021A1515012496, 2022A1515012221)
- National Natural Science Foundation of China (81871996, 81973174, 82003218, 82072029, 82172812, 82272743)
This publication has 51 references indexed in Scilit:
- The ubiquitin specific protease USP34 promotes ubiquitin signaling at DNA double-strand breaksNucleic Acids Research, 2013
- The role of deubiquitinating enzymes in chromatin regulationFEBS Letters, 2010
- Enhancement of proteasome activity by a small-molecule inhibitor of USP14Nature, 2010
- HERC2 Is an E3 Ligase That Targets BRCA1 for DegradationCancer Research, 2010
- Regulation and Cellular Roles of Ubiquitin-Specific Deubiquitinating EnzymesAnnual Review of Biochemistry, 2009
- BRCA1-Associated Protein 1 Interferes with BRCA1/BARD1 RING Heterodimer ActivityCancer Research, 2008
- E2–BRCA1 RING interactions dictate synthesis of mono- or specific polyubiquitin chain linkagesNature Structural & Molecular Biology, 2007
- TRF2 is required for repair of nontelomeric DNA double-strand breaks by homologous recombinationProceedings of the National Academy of Sciences, 2007
- BRCA1/2 mutation testing in breast cancer patients: a prospective study of the long-term psychological impact of approach during adjuvant radiotherapyBreast Cancer Research and Treatment, 2007
- Adenovirus‐mediated intra‐tumoral delivery of the human endostatin gene inhibits tumor growth in nasopharyngeal carcinomaInternational Journal of Cancer, 2005